Skip to main content
. 2016 Apr 18;7(21):29977–29988. doi: 10.18632/oncotarget.8796

Table 3. Geriatric assessment results at baseline (T0), 3 months (T1), and 1 year (T2), and their differential evolution over time in Chemo and Control Groups.

Chemo Group (n=57) Evolution Over Time Chemo Group Control Group (n=52) Evolution Over Time Control Group Differential Evolution (Time Interaction)
T0 T1 T2 T0 → T1 T0 → T2 T0 T1 T2 T0 → T1 T0 → T2
Frailty(Balducci) N
Fit n (%)
Vulnerable n (%)
Frail n (%)
56
12 (21)
21 (35)
23 (41)
53
8 (15)
23 (43)
22 (42)
48
10 (21)
15 (31)
23 (48)


p=0.87


p=0.41
52
10 (19)
17 (33)
25 (48)
48
9 (19)
13 (27)
26 (54)
46
7 (15)
13 (28)
26 (57)


p=0.34


p=0.77
p=0.63α
LOFS N
Mean +/− SD
56
7.5 +/− 2
53
6.7 +/− 2
48
7.4 +/− 2
p<0.01 p=0.60 51
6.8 +/− 2
48
7.0 +/− 2
46
6.8 +/− 2

p=0.48

p=0.45


p<0.01
ADL N
Mean +/− SD
6§ n (%)
0-5 n (%)
56
5.5 +/− 1
33 (59)
23 (41)
56
5.4 +/− 1
35 (62)
21 (37)
51
5.5 +/− 1
30 (59)
21 (41)


p=0.88
p=0.88


p=0.96
p=0.99
52
5.1 +/− 1
29 (56)
23 (44)
48
5.0 +/− 1
23 (48)
25 (52)
46
5.0 +/− 1
21 (46)
25 (54)

p=0.94
p=0.85

p=0.57
p=0.47

p=0.77
p=0.76
IADL N
Mean +/− SD
8§ n (%)
0-7 n (%)
57
6.6 +/− 2
24 (42)
33 (58)
56
6.0 +/− 2
16 (29)
40 (71)
51
6.8 +/− 2
26 (51)
25 (49)
p<0.01
p=0.01
p=0.39
p=0.39
52
5.8 +/− 2
17 (33)
35 (67)
48
5.8 +/− 2
17 (35)
31 (65)
46
5.7 +/− 3
17 (37)
29 (63)

p=0.71
p=0.75

p=0.57
p=0.60

p<0.01
p=0.01
Previous falls N
 No n (%)
 Yes n (%)
57
44 (77)
13 (23)
N/A 50
34 (68)
16 (32)
N/A
p=0.28
p=0.25
52
28 (54)
24 (46)
N/A 46
29 (63)
17 (37)
N/A
p=0.33
p=0.37

p=0.15β
p=0.15 β
MMSE N
 Mean +/− SD
57
27.9 +/− 2
56
27.6 +/− 3
51
27.9 +/− 3


p=0.22
p=0.19


p=0.94
p=0.96
52
27.9 +/− 2
48
27.8 +/− 3
46
27.9 +/− 4

p=0.34
p=0.31

p=0.40
p=0.41

p=0.77
p=0.78
GDS-15 N
 Mean +/− SD
 0-4§ n (%)
 5-15 n (%)
55
2.9 +/− 2
46 (84)
9 (16)
56
3.1 +/− 2
43 (77)
13 (23)
50
3.1 +/− 3
38 (76)
12 (24)

p=0.31
p=0.23

p=0.50
p=0.51
46
2.8 +/− 2
35 (76)
11 (24)
47
3.5 +/− 3
32 (68)
15 (32)
45
3.1 +/− 3
35 (78)
10 (22)

p=0.23
p=0.25

p=0.40
p=0.40


p=0.98
p=0.98
MNA-SF N
 Mean +/− SD
 ≥ 12§ n (%)
 < 11 n (%)
57
11.1 +/− 2
25 (44)
32 (56)
55
9.9 +/− 2
16 (29)
39 (71)
50
11.5 +/− 2
27 (54)
23 (46)

p<0.01
p<0.01

p=0.19
p=0.13
51
11.0 +/− 2
23 (45)
28 (55)
48
11.3 +/− 2
29 (60)
19 (40)
46
11.4 +/− 2
23 (50)
23 (50)

p=0.24
p=0.32

p=0.23
p=0.21


p<0.01
p<0.01
CCI N
 Mean +/− SD
 0§ n (%)
 1 n (%)
 >=2 n (%)
54
0.6 +/− 1
32 (59)
12 (22)
10 (19)
53
0.7 +/− 1
32 (60)
10 (19)
11 (21)
49
0.7 +/− 1
28 (57)
12 (25)
9 (18)


p=0.42
p=0.48


p=0.16
p=0.78
52
1.1 +/− 2
27 (52)
12 (23)
13 (25)
50
1.1 +/− 2
27 (54)
10 (20)
13 (26)
46
1.2 +/− 2
22 (48)
11 (24)
13 (28)


p=0.86
p=0.97


p=0.35
p=0.91


p=0.63θ
p=0.86 θ
G8 N
 Mean +/− SD
 >14 n (%)
 ≤ 14 n (%)
56
14.2 +/− 2
28 (50)
28 (50)
NA NA N/A N/A 52
13.7 +/− 2
22 (42)
30 (58)
NA NA N/A N/A N/A
Global QoL N
 Mean +/− SD
57
64.2 +/− 17
56
58.5 +/− 20
50
69.5 +/− 22

p=0.06
p=0.05

p=0.11
p=0.08
52
63.8 +/− 17
48
64.6 +/− 20
46
63.6 +/− 23
p=0.83
p=0.83
p=0.73
p=0.96
p=0.02
p=0.03

Abbreviations. SD: Standard Deviation; CI: Confidence Interval; ADL: Activities of Daily Living; IADL: Instrumental Activities of Daily Living; MMSE: Mini Mental State Examination; GDS: Geriatric Depression Scale; MNA-SF: Mini Nutritional Assessment-Short Form; MNA: Mini Nutritional Assessment

§: Maximum score, no abnormalities

α: calculation based on probability of being fit or vulnerable by time and study arm

β: calculation based on probability of falling by time and study arm

θ: calculation based on probability of having the lowest score at CCI, by time and study arm

p-values in italic font show results corrected for patient frailty level at baseline